Schmitl, S., Kretschmer-Chott, E., Patronas, E., Kramer, G., Ritt, P., Fuchs, E., . . . Hacker, M. (2025). Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients. Journal of Nuclear Medicine, 66(8), 1239. https://doi.org/10.2967/jnumed.125.269655
Chicago Style (17th ed.) CitationSchmitl, Stefan, et al. "Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients." Journal of Nuclear Medicine 66, no. 8 (2025): 1239. https://doi.org/10.2967/jnumed.125.269655.
MLA (9th ed.) CitationSchmitl, Stefan, et al. "Efficacy, Safety, Blood Kinetics, and 213Bi Distribution Studies of [225Ac]Ac-SibuDAB in Prostate Cancer Patients." Journal of Nuclear Medicine, vol. 66, no. 8, 2025, p. 1239, https://doi.org/10.2967/jnumed.125.269655.